Association of TNF receptor 2 and CRP with GFR decline in the general nondiabetic population

Clinical Journal of the American Society of Nephrology

Volumn 12, Issue 4, 2017, Pages 624-634

  Schei, Jørgen ^a,b   Stefansson, Vidar Tor Nyborg ^a   Eriksen, Bjørn Odvar ^a,b   Jenssen, Trond Geir ^a,c   Solbu, Marit Dahl ^a,b   Wilsgaard, Tom ^a   Melsom, Toralf ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Aging; C reactive protein; Cardiovascular diseases; Chronic; Chronic kidney disease; Cytokines; Diabetes mellitus; Follow up studies; GFR decline; Glomerular filtration rate; Human; Humans; Inflammation; Iohexol; Kidney; Kidney function tests; Logistic models; Measured GFR; Middle aged; Odds ratio; Receptors; Renal insufficiency; Soluble TNF receptors; Surveys and questionnaires; TNFRSF1B protein; Tumor necrosis factor; Type II

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IOHEXOL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; CONTRAST MEDIUM; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEALTH CARE SURVEY; HUMAN; HUMAN EXPERIMENT; MALE; MIDDLE AGED; RENAL IOHEXOL CLEARANCE SURVEY; TOBACCO USE; AGED; AGING; BLOOD; CHRONIC KIDNEY FAILURE; METABOLISM; PATHOPHYSIOLOGY; SWEDEN;

AGED; AGING; C-REACTIVE PROTEIN; CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; IOHEXOL; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RENAL INSUFFICIENCY, CHRONIC; SWEDEN;

EID: 85021685265     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09280916     Document Type: Article

References (47)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038–2047, 2007
2. Stevens LA, Coresh J, Levey AS: CKD in the elderly–old questions and new challenges: World Kidney Day 2008. Am J Kidney Dis 51: 353–357, 2008
3. Halbesma N, Brantsma AH, Bakker SJ, Jansen DF, Stolk RP, De Zeeuw D, De Jong PE, Gansevoort RT; PREVEND study group: Gender differences in predictors of the decline of renal function in the general population. Kidney Int 74: 505–512, 2008
4. Kronborg J, Solbu M, Njølstad I, Toft I, Eriksen BO, Jenssen T: Predictors of change in estimated GFR: A population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant 23: 2818–2826, 2008
5. Navarro JF, Mora-Fernández C: The role of TNF-alpha in diabetic nephropathy: Pathogenic and therapeutic implications. Cytokine Growth Factor Rev 17: 441–450, 2006
6. Carlsson AC, Larsson TE, Helmersson-Karlqvist J, Larsson A, Lind L, Ärnlöv J: Soluble TNF receptors and kidney dysfunction in the elderly. J Am Soc Nephrol 25: 1313–1320, 2014
7. Hiramoto JS, Katz R, Peralta CA, Ix JH, Fried L, Cushman M, Siscovick D, Palmas W, Sarnak M, Shlipak MG: Inflammation and coagulation markers and kidney function decline: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 60: 225–232, 2012
8. Kurashina T, Nagasaka S, Watanabe N, Yabe D, Sugi N, Nin K, Hosokawa M, Nomura Y, Fukushima M, Nakai Y, Nishimura F, Taniguchi A: Circulating TNF receptor 2 is closely associated with the kidney function in non-diabetic Japanese subjects. J Atheroscler Thromb 21: 730–738, 2014
9. Lin J, Hu FB, Rimm EB, Rifai N, Curhan GC: The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus. Kidney Int 69: 336–342, 2006
10. Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Roshan B, Warram JH, Krolewski AS: Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol 4: 62–70, 2009
11. Shankar A, Sun L, Klein BE, Lee KE, Muntner P, Nieto FJ, Tsai MY, Cruickshanks KJ, Schubert CR, Brazy PC, Coresh J, Klein R: Markers of inflammation predict the long-term risk of developing chronic kidney disease: A population-based cohort study. Kidney Int 80: 1231–1238, 2011
12. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G; Cholesterol and Recurrent Events (CARE) Trial Investigators: Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68: 237–245, 2005
13. Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM, Mayadas TN, Warram JH, Krolewski AS: Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J AmSoc Nephrol 23: 516–524, 2012
14. Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, Cullere X, Eckfeldt JH, Doria A, Mayadas TN, Warram JH, Krolewski AS: Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 23: 507–515, 2012
15. Skupien J, Warram JH, Niewczas MA, Gohda T, Malecki M, Mychaleckyj JC, Galecki AT, Krolewski AS: Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria. Diabetes Care 37: 2601–2608, 2014
16. Lin J, Hu FB, Mantzoros C, Curhan GC: Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes. Diabetologia 53: 263–267, 2010
17. Pavkov ME, Nelson RG, Knowler WC, Cheng Y, Krolewski AS, Niewczas MA: Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes. Kidney Int 87: 812–819, 2015
18. Medenwald D, Girndt M, Loppnow H, Kluttig A, Nuding S, Tiller D, Thiery JJ, Greiser KH, Haerting J, Werdan K: Inflammation and renal function after a four-year follow-up in subjects with unimpaired glomerular filtration rate: Results from the observational, population-based CARLA cohort. PLoS One 9: e108427, 2014
19. Carlsson AC, Nordquist L, Larsson TE, Carrero JJ, Larsson A, Lind L, Ärnlöv J: Soluble tumor necrosis factor receptor 1 is associated with glomerular filtration rate progression and incidence of chronic kidney disease in two community-based cohorts of elderly individuals. Cardiorenal Med 5: 278–288, 2015
20. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20–29, 2012
21. Schei J, Stefansson VT, Mathisen UD, Eriksen BO, Solbu MD, Jenssen TG, Melsom T: Residual associations of inflammatory markers with eGFR after accounting for measured GFR in a community-based cohort without CKD. Clin J Am Soc Nephrol 11: 280–286, 2015
22. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS: Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75: 652–660, 2009
23. Fan L, Levey AS, Gudnason V, Eiriksdottir G, Andresdottir MB, Gudmundsdottir H, Indridason OS, Palsson R, Mitchell G, Inker LA: Comparing GFR estimating equations using cystatin C and creatinine in elderly individuals. J Am Soc Nephrol 26: 1982– 1989, 2015
24. Eriksen BO, Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I: Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 78: 1305–1311, 2010
25. Nilsson-Ehle P: Iohexol clearance for the determination of glomerular filtration rate: 15 years´ experience in clinical practice. EJIFCC 13: 1–5, 2006
26. Jacobsson L: A method for the calculation of renal clearance based on a single plasma sample. Clin Physiol 3: 297–305, 1983
27. Eriksen BO, Stefansson VT, Jenssen TG, Mathisen UD, Schei J, Solbu MD, Wilsgaard T, Melsom T: Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population. Kidney Int 90: 404–410, 2016
28. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njolstad I: Cohort profile: the Tromso Study. Int J Epidemiol 41: 961–967, 2012
29. Melsom T, Fuskevåg OM, Mathisen UD, Strand H, Schei J, Jenssen T, Solbu M, Eriksen BO: Estimated GFR is biased by nontraditional cardiovascular risk factors. Am J Nephrol 41: 7–15, 2015
30. Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I, Eriksen BO: Ambulatory blood pressure is associated with measured glomerular filtration rate in the general middle-aged population. J Hypertens 30: 497–504, 2012
31. Solbu MD, Kronborg J, Eriksen BO, Jenssen TG, Toft I: Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: A gender-specific follow-up study. Atherosclerosis 201: 398–406, 2008
32. Boucquemont J, Heinze G, Jager KJ, Oberbauer R, Leffondre K: Regression methods for investigating risk factors of chronic kidney disease outcomes: The state of the art. BMC Nephrol 15: 45, 2014
33. Leffondre K, Boucquemont J, Tripepi G, Stel VS, Heinze G, Dunkler D: Analysis of risk factors associated with renal function trajectory over time: A comparison of different statistical approaches. Nephrol dial transplant 30: 1237–1243, 2014
34. Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ: Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 168: 2212–2218, 2008
35. Royston P, Sauerbrei W: Multivariable Model-building, Chichester, John Wiley & Sons Ltd, 2008
36. Kushner I, Rzewnicki D, Samols D: What does minor elevation of C-reactive protein signify? Am J Med 119: 166.e17–166.e28, 2006
37. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33: 278–285, 1985
38. Rule AD, Bailey KR, Lieske JC, Peyser PA, Turner ST: Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int 83: 1169–1176, 2013
39. Bemelmans MH, Gouma DJ, Buurman WA: Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine 6: 608–615, 1994
40. Kugler E, Cohen E, Goldberg E, Nardi Y, Levi A, Krause I, Garty M, Krause I: C reactive protein and long-term risk for chronic kidney disease: A historical prospective study. J Nephrol 28: 321–327, 2015
41. Har R, Scholey JW, Daneman D, Mahmud FH, Dekker R, Lai V, Elia Y, Fritzler ML, Sochett EB, Reich HN, Cherney DZ: The effect of renal hyperfiltration on urinary inflammatory cytokines/ chemokines in patients with uncomplicated type 1 diabetes mellitus. Diabetologia 56: 1166–1173, 2013
42. Har RL, Reich HN, Scholey JW, Daneman D, Dunger DB, Moineddin R, Dalton RN, Motran L, Elia Y, Deda L, Ostrovsky M, Sochett EB, Mahmud FH, Cherney DZ: The urinary cytokine/ chemokine signature of renal hyperfiltration in adolescents with type 1 diabetes. PLoS One 9: e111131, 2014
43. Kodera R, Shikata K, Kataoka HU, Takatsuka T, Miyamoto S, Sasaki M, Kajitani N, Nishishita S, Sarai K, Hirota D, Sato C, Ogawa D, Makino H: Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Diabetologia 54: 965–978, 2011
44. Costello-White R, Ryff CD, Coe CL: Aging and low-grade inflammation reduce renal function in middle-aged and older adults in Japan and the USA. Age (Dordr) 37: 9808, 2015
45. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175: 323–329, 1992
46. Bird NJ, Peters C, Michell AR, Peters AM: Comparison of GFR measurements assessed from single versus multiple samples. Am J Kidney Dis 54: 278–288, 2009
47. Stevens LA, Levey AS: Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 20: 2305–2313, 2009